AffyImmune Therapeutics names new senior vice president and head of Clinical Development
26 April 2022 -

AffyImmune Therapeutics, Inc., a US-based clinical stage biotechnology company, announced on Monday that it has named Sonal Gupta, MD, PhD as its new senior vice president and head of Clinical Development.

Dr Gupta has worked at AVROBIO, Rubius Therapeutics and CRISPR Therapeutics. She holds her PhD in cancer research from the University of Bradford in the UK, and her medical degree from the Government Medical College, Surat in India.

Matt Britz, AffyImmune Therapeutics president, said, 'As immuno-oncology continues to rapidly evolve, we are delighted to welcome a clinician as talented and experienced as Sonal to Affy. Her oversight of our clinical and pipeline programs and passion for bringing new and innovative therapies to patients with solid tumours will strengthen Affy's Tune & Track platform and our senior leadership team.'